Synthesis of Modified Prolines
was dried over Na2SO4, and the solvent removed in vacuo.
Products were purified by column chromatography over SiO2
with the appropriate mixture of ethyl acetate/hexane. Com-
pound 19, prepared from 18, was used in the next step without
further purification.
Meth yl (-)-(2S,3R)-2-[(R)-1-Ben zyloxyca r bon yl-4-(ter t-
bu tyld im eth ylsilyloxy)p yr r olid in -2-yl]-3-(N-ter t-bu toxy-
ca r bon yla m in o)p r op a n oa te (1a ). Prepared from 17a , and
purified through flash chromatography (20% EtOAc/hexane),
to afford 270 mg of 1a , in 93% yield. Colorless oil, [R]D -26.1
(c 0.6, CHCl3). 1H NMR (300 MHz, CDCl3) δ -0.10 (s, 3H),
-0.09 (s, 3H), 0.80 (s, 9H), 1.37 (s, 9H), 2.17-2.38 (m, 2H),
3.12 (dd, J ) 11.1, 5.4 Hz, 1H), 3.35-3.50 (m, 2H), 3.77 (s, 3H),
5.16-5.40 (m, 3H), 7.12-7.45 (m, 10H), 8.02 (d, J ) 9.1 Hz,
1H); 13C NMR (75 MHz, CDCl3) δ -5.1, 17.7, 25.5, 28.3, 45.7,
52.4, 57.1, 59.6, 67.1, 67.2, 72.9, 78.8, 127.4, 127.6, 127.9, 128.1,
128.4, 128.8, 136.5, 138.0, 155.2, 156.5, 170.9; IR (neat) 1711,
1757, 3356 cm-1; MS (ESI+) m/z (rel intensity) 637 [(M + K),
100], 621 [(M + Na), 85]; HRMS calcd for (C32H46N2O7Si-tBuO)
525.2415, found 525.2414. Anal. Calcd for C32H46N2O7Si: C,
64.19; H, 7.74; N, 4.68. Found: C, 64.38; H, 7.71; N, 4.70.
Meth yl (+)-(2R,3R)-2-[1-Ben zyloxyca r bon ylp yr r olid in -
2-yl]-3-(N-ter t-bu toxyca r bon yla m in o)-3-[(S)-2,2-d im eth -
yl-1,3-d ioxola n -4-yl]p r op a n oa te (1b). Prepared from 17b,
and purified through flash chromatography (25% EtOAc/
hexane), to afford 172 mg of 1b, in 70% yield. White foam,
[R]D +36.9 (c 0.3, CHCl3). 1H and 13C NMR show the presence
of rotamers in ca. 2:1 ratio. 1H NMR (300 MHz, CDCl3) δ 1.20-
1.45 (m, 15H), 1.62-2.43 (m, 4H), 3.28-3.89 (m, 6H), 4.03-
4.18 (m, 1H), 4.30-4.61 (m, 2H), 4.85-5.45 (m, 2H), 6.19 (d,
J ) 9.4, 1H), 7.32 (m, 5H); 13C NMR (75 MHz, CDCl3) δ 23.2,
25.7, 26.0, 28.3, 34.3, 35.4, 48.7, 48.9, 51.9, 52.3, 53.4, 66.9,
67.1, 67.5, 67.8, 71.0, 74.0, 74.7, 79.0, 79.5, 109.2, 109.5, 127.7,
127.8, 128.2, 128.3, 128.5, 136.5, 136.7, 153.6, 155.1, 155.7,
155.9, 172.9, 173.5; IR (neat) 1707, 1739, 3368 cm-1; MS (ESI+)
m/z (rel intensity) 493 [(M + H), 38], 393 [(M - Boc + 2H),
58]; HRMS calcd for C25H36N2O3 492.2472, found 492.2496.
Anal. Calcd for C25H36N2O8: C, 60.96; H, 7.37; N, 5.69.
Found: C, 60.79; H, 7.39; N, 5.71.
(-)-(3R,4S,7R)-5-Ben zyloxyca r bon yl-2-(ter t-bu toxyca r -
bon yl)-7-(ter t-bu tyld im eth ylsilyloxy)-3-p h en yl-2,5-d ia za -
sp ir o[3.4]octa n -1-on e (17a ). Prepared from 16a (1 mmol)
according to the general procedure described above to afford,
after flash chromatography (33% EtOAc/hexane), 329 mg of
17a , in 58% yield (2 steps). Pale yellow solid, [R]D -84.9 (c
0.4, CHCl3), mp 110-112 °C. 1H and 13C NMR show the
presence of rotamers about the carbamate bond in ca. 1:1 ratio.
1H NMR (300 MHz, CDCl3) δ 0.08, 0.11, 0.12, 0.13 (s, 6H),
0.89, 0.90 (s, 9H), 1.41, 1.50 (s, 9H), 2.42-2.58 (m, 2H), 3.17,
3.30 (dd, J ) 10.2, 7.7 Hz; dd, J ) 10.5, 7.7 Hz, 1H), 3.46,
3.60 (dd, J ) 10.2, 7.4 Hz; dd, J ) 10.5, 7.4 Hz, 1H), 4.45,
4.71 (d, J ) 12.0 Hz; d, J ) 12.5 Hz, 1H), 4.50-4.66 (m, 1H),
4.85-5.01 (m, 2H), 6.69 (m, 1H), 6.98 (m, 1H), 7.12-7.45 (m,
8H); 13C NMR (75 MHz, CDCl3) δ -5.0, -4.9, 17.9, 25.6, 27.8,
27.9, 43.1, 44.4, 53.7, 54.4, 66.9, 67.9, 67.7, 68.4, 69.0, 69.3,
75.6, 76.1, 83.5, 83.6, 126.0, 126.5, 127.6, 127.8, 128.0, 128.3,
128.4, 133.0, 133.3, 135.0, 136.1, 147.9, 148.3, 152.8, 153.4,
164.8, 165.5; IR (KBr) 1713, 1814 cm-1; MS (ESI+) m/z (rel
intensity) 1155 [(2M + Na), 100], 589 [(M + Na), 25]. Anal.
Calcd for C31H42N2O6Si: C, 65.69; H, 7.47; N, 4.94. Found: C,
65.82; H, 7.50; N, 4.93.
(-)-(3R,4R)-5-Ben zyloxyca r bon yl-2-(ter t-bu toxyca r bo-
n yl)-3-[(S)-2,2-d im eth yl-1,3-d ioxola n -4-yl]-2,5-d ia za sp ir o-
[3.4]octa n -1-on e (17b). Prepared from 16b (0.6 mmol) ac-
cording to the general procedure described above to afford,
after flash chromatography (50% EtOAc/hexane), 260 mg of
17b, in 94% yield. White solid, [R]D -0.4 (c 3, CHCl3), mp
)113-117 °C. 1H and 13C NMR show the presence of rotamers
about the carbamate bond in ca. 2.5:1 ratio. 1H NMR (300
MHz, CDCl3) δ 1.05-1.50 (m, 15H), 1.60-2.41 (m, 4H), 3.30-
3.94 (m, 5H), 4.07, 4.53 (m, 1H), 4.89-5.32 (m, 2H), 7.32 (m,
5H); 13C NMR (75 MHz, CDCl3) δ 22.3, 23.1, 24.9, 25.0, 26.3,
26.4, 27.7, 27.8, 35.3, 36.6, 47.8, 48.5, 65.9, 67.6, 68.1, 70.1,
70.6, 73.9, 74.1, 74.8, 74.9, 83.0, 109.0, 128.0, 128.2, 128.3,
128.4, 128.5, 134.8, 135.8, 147.4, 147.6, 153.3, 154.0, 166.2,
166.6; IR (KBr) 1704, 1738, 1796 cm-1; MS (ESI+) m/z (rel
intensity) 483 [(M + Na), 100]. Anal. Calcd for C24H32N2O7:
C, 62.59; H, 7.00; N, 6.08. Found: C, 62.38; H, 7.01; N, 6.06.
Meth yl (-)-(2S,3R)-2-[1-Ben zyloxyca r bon ylp yr r olid in -
2-yl]-3-(N-ter t-bu toxyca r bon yla m in o)-3-[(R)-3-ter t-bu tox-
yca r b on yl-2,2-d im et h yl-1,3-oxa zolid in -4-yl]p r op a n oa t e
(1c). Prepared from 17c, and purified through flash chroma-
tography (33% EtOAc/hexane), to afford 250 mg of 1c, in 85%
yield. White foam, [R]D -42.8 (c 0.5, CHCl3). 1H and 13C NMR
1
show the presence of rotamers in ca. 1:1 ratio. H NMR (300
MHz, CDCl3) δ 1.30-1.55 (m, 24H), 1.70-2.46 (m, 4H), 3.42-
3.96 (m, 8H), 4.64, 4.75 (dd, J ) 10.1, 4.4 Hz; dd, J ) 9.7, 4.8
Hz, 1H), 5.09 (m, 2H), 6.05, 6.26 (d, J ) 10.5 Hz; d, J ) 10.2
Hz, 1H), 7.34 (m, 5H); 13C NMR (75 MHz, CDCl3) δ 22.9, 23.3,
24.2, 26.1, 26.8, 28.2, 28.4, 28.6, 36.0, 36.6, 48.5, 48.6, 51.8,
52.1, 56.7, 57.2, 57.4, 67.1, 67.2, 67.6, 67.7, 70.7, 70.9, 78.6,
79.3, 80.0, 80.5, 93.0, 93.6, 127.7, 128.0, 128.3, 128.4, 129.2,
136.3, 136.5, 152.4, 153.7, 154.9, 155.3, 156.2, 156.5, 171.5,
171.9; IR (KBr) 1697, 1701, 1747, 3447 cm-1; MS (ESI+) m/z
(rel intensity) 630 [(M + K), 100], 614 [(M + Na), 80]; HRMS
calcd for C30H45N3O9 591.3156, found 591.3178. Anal. Calcd
for C30H45N3O9: C, 60.90; H, 7.67; N, 7.10. Found: C, 60.99;
H, 7.70; N, 7.13.
Meth yl (+)-(2R,3R)-2-[1-Ben zyloxyca r bon ylp yr r olid in -
2-yl]-3-(N-ter t-bu toxyca r bon yla m in o)-4-(ter t-bu tyld im e-
th ylsilyloxy)bu ta n oa te (1d ). Prepared from 19 (0.5 mmol),
and purified through flash chromatography (33% EtOAc/
hexane), to afford 166 mg of 1d , in 62% yield (2 steps).
Colorless oil, [R]D +3.1 (c 0.16, CHCl3). 1H NMR (300 MHz,
CDCl3) δ 0.00 (s, 3H), 0.03 (s, 3H), 0.86 (s, 9H), 1.42 (s, 9H),
1.65-1.96 (m, 2H), 2.32 (m, 1H), 2.58 (m, 1H), 3.38-3.84 (m,
7H), 4.34 (m, 1H), 5.10-5.24 (m, 2H), 6.47 (d, J ) 10.0, 1H),
7.35 (m, 5H); 13C NMR (75 MHz, CDCl3) δ -5.7, 18.0, 22.1,
25.7, 28.3, 36.8, 49.0, 52.3, 54.6, 63.2, 67.1, 72.7, 78.7, 127.5,
127.9, 128.3, 128.4, 136.5, 155.5, 155.9, 172.1; MS (ESI+) m/z
(rel intensity) 575 [(M + K), 42], 559 [(M + Na), 18]. Anal.
Calcd. for C27H44N2O7Si: C, 60.42; H, 8.26; N, 5.22. Found:
C, 60.23; H, 8.24; N, 5.25.
(-)-(3R,4S)-5-Ben zyloxyca r bon yl-2-(ter t-bu toxyca r bo-
n yl)-3-[(R)-3-ter t-bu toxyca r bon yl-2,2-d im eth yl-1,3-oxa zo-
lid in -4-yl]-2,5-d ia za sp ir o[3.4]octa n -1-on e (17c). Prepared
from 16c (0.6 mmol) according to the general procedure
described above to afford, after flash chromatography (33%
EtOAc/hexane), 238 mg of 17c, in 71% yield. Colorless oil, [R]D
-4.6 (c 0.9, CHCl3). 1H and 13C NMR show the presence of
1
rotamers. H NMR (300 MHz, CDCl3) δ 1.35-1.65 (m, 24H),
1.70-2.42 (m, 4H), 3.36-3.82 (m, 4H), 3.88-4.09 (m, 1H),
4.42-4.63 (m, 1H), 4.95-5.30 (m, 2H), 7.34 (m, 5H); 13C NMR
(75 MHz, CDCl3) δ 22.2, 22.9, 23.2, 24.5, 26.9, 27.5, 28.1, 28.3,
28.4, 35.7, 37.2, 48.3, 49.0, 56.5, 56.8, 64.8, 65.1, 67.5, 67.7,
68.4, 74.4, 74.6, 79.7, 79.9, 80.6, 82.7, 83.6, 93.8, 94.4, 128.1,
128.3, 129.4, 136.0, 136.3, 148.3, 148.7, 152.2, 152.3, 152.7,
153.9 154.3, 165.6, 166.4; IR (KBr) 1698, 1732, 1821 cm-1; MS
(ESI+) m/z (rel intensity) 598 [(M + K), 10], 582 [(M + Na),
100]. Anal. Calcd for C29H41N3O8: C, 62.24; H, 7.38; N, 7.51.
Found: C, 62.36; H, 7.35; N, 7.54.
Syn t h esis of r-(1-Am in oa lk yl)p r olin e Met h yl E st er s
(1). To a stirred solution of the N-Boc-â-lactam (17 and 18)
(0.5 mmol) in MeOH (10 mL) was added potassium cyanide
(0.5 mmol) and the mixture was stirred overnight. The MeOH
was removed in vacuo and saturated aqueous NaHCO3 (10 mL)
and EtOAc (10 mL) were added. The aqueous layer was
extracted with EtOAc (2 × 15 mL) and the combined organic
layers washed with brine, dried over anhydrous Na2SO4, and
concentrated in vacuo. Flash chromatography afforded the
desired N-Boc-protected proline derivatives.
Ack n ow led gm en t. A.M. acknowledges a fellowship
from FICYT (Regional Government of Principado de
Asturias). The authors are very grateful to Prof. F.
J . Org. Chem, Vol. 69, No. 21, 2004 7011